Health Care: Drugs

Alkermes PLC (ALKS: NASDAQ)

$39.44 -0.92 | -2.28%
05/03/16 - 12:02 PM ET
Company Profile
Price and Volume
Recent Price 40.36
52 Week High 80.71
52 Week Low 27.14
Avg. Daily Vol. (Mil) 1.60
Beta (3 year) 2.02
Share Related Items
Mkt Cap (Mil) 6,101.04
Shares Out (Mil) 151.17
Float (Mil) 90.58
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.40
Current Ratio 3.70
LT Debt/ Equity 0.22
Total Debt / Equity 0.28
Valuation Ratios
Price Earnings n.a.
Price/Sales 9.78
Price/Book 4.82
Price/Cash Flow -32.40
Per Share Data
Earnings -1.83
Sales 4.13
Book Value 8.37
Cash Flow -1.24
Business Summary
Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients.
General Information
1 Burlington Road
Connaught House
Dublin, 4
www.alkermes.com
Industry : Drugs
Sector: Health Care
Employees: 1500
CEO: Richard F. Pops
Short Interest
Current Month (Mil) 6.46
Previous Month (Mil) 6.45
Short Interest Ratio (Days) 3.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -15.30
Return on Investments -17.70
Profitability
Gross Margin 84.20
EBIT Margin -41.30
Profit Margin -43.90

Portfolios with ALKS

Latest ALKS Headlines from TheStreet

More Financial News for ALKS

Press Releases for ALKS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter